Comparison of the Effects of Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals at Increased Cardiometabolic Risk

University of Erlangen-Nürnberg Medical School1 site in 1 country100 target enrollmentNovember 1, 2017

ConditionsOverweight and Obesity Metabolic Syndrome

Overview

Phase: N/A
Intervention: Not specified
Conditions: Overweight and Obesity
Sponsor: University of Erlangen-Nürnberg Medical School
Enrollment: 100
Locations: 1
Primary Endpoint: Metabolic Syndrome Z-Score (MetS-Z-Score)
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The main purpose of this study is to compare the effects of whole-body electromyostimulation versus a conventional low-volume strength-training program, each combined with an individualized, weight-reducing diet, on the cardiometabolic risk profile, muscle strength, body composition, inflammatory markers and subjective health outcomes in overweight individuals at increased cardiometabolic risk.

Registry

clinicaltrials.gov

Start Date

November 1, 2017

End Date

September 30, 2020

Last Updated

7 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Erlangen-Nürnberg Medical School

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Body Mass Index \>25
•presence of at least 2 cardiometabolic risk factors

Exclusion Criteria

•Healthy persons or patients under age
•Overweight persons without any additional cardiometabolic risk factors
•Pregnancy, Lactation
•Psychological disorders, epilepsy, sever neurological disorders
•Participation in other exercise- or nutrition studies within the last 6 months
•acute cardiovascular disease
•malignant disease
•Intake of anabolic drugs,
•Skin injuries in the area of electrode placements
•Electronic implants (defibrillator, pacemaker)

Outcomes

Primary Outcomes

Metabolic Syndrome Z-Score (MetS-Z-Score)

Time Frame: 12 weeks (baseline to 12 week follow-up assessment)

MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.

Secondary Outcomes

Muscle strength(12 weeks (baseline to 12 week follow-up assessment))
Body Composition(12 weeks (baseline to 12 week follow-up assessment))
Cardiorespiratory Fitness (CRF)(12 weeks (baseline to 12 week follow-up assessment))
Inflammation status(12 weeks (baseline to 12 week follow-up assessment))
Health-related quality of life(12 weeks (baseline to 12 week follow-up assessment))
Pain scores(12 weeks (baseline to 12 week follow-up assessment))
Perceived stress(12 weeks (baseline to 12 week follow-up assessment))
Subjective work ability(12 weeks (baseline to 12 week follow-up assessment))